1. Home
  2. HNI vs BLTE Comparison

HNI vs BLTE Comparison

Compare HNI & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNI
  • BLTE
  • Stock Information
  • Founded
  • HNI 1944
  • BLTE 2018
  • Country
  • HNI United States
  • BLTE United States
  • Employees
  • HNI N/A
  • BLTE N/A
  • Industry
  • HNI Office Equipment/Supplies/Services
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNI Consumer Discretionary
  • BLTE Health Care
  • Exchange
  • HNI Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • HNI 1.9B
  • BLTE 1.9B
  • IPO Year
  • HNI N/A
  • BLTE 2022
  • Fundamental
  • Price
  • HNI $46.63
  • BLTE $61.09
  • Analyst Decision
  • HNI Strong Buy
  • BLTE Strong Buy
  • Analyst Count
  • HNI 1
  • BLTE 4
  • Target Price
  • HNI $63.00
  • BLTE $96.67
  • AVG Volume (30 Days)
  • HNI 273.5K
  • BLTE 32.2K
  • Earning Date
  • HNI 05-07-2025
  • BLTE 05-14-2025
  • Dividend Yield
  • HNI 2.87%
  • BLTE N/A
  • EPS Growth
  • HNI 100.29
  • BLTE N/A
  • EPS
  • HNI 2.80
  • BLTE N/A
  • Revenue
  • HNI $2,538,200,000.00
  • BLTE N/A
  • Revenue This Year
  • HNI $3.27
  • BLTE N/A
  • Revenue Next Year
  • HNI $3.99
  • BLTE N/A
  • P/E Ratio
  • HNI $15.64
  • BLTE N/A
  • Revenue Growth
  • HNI N/A
  • BLTE N/A
  • 52 Week Low
  • HNI $39.76
  • BLTE $40.00
  • 52 Week High
  • HNI $58.42
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • HNI 66.15
  • BLTE 50.91
  • Support Level
  • HNI $42.47
  • BLTE $59.62
  • Resistance Level
  • HNI $47.10
  • BLTE $63.37
  • Average True Range (ATR)
  • HNI 1.20
  • BLTE 2.40
  • MACD
  • HNI 0.58
  • BLTE 0.39
  • Stochastic Oscillator
  • HNI 85.85
  • BLTE 75.04

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: